Money never sleeps pal. I just made $800,000 in Hong Kong gold. It's been wired to you -- play with it. You done good, but you gotta keep doing good.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
JIMMER ......JIMMER>>>>>>>>>>>>>JIMMER!!!!!!!!!!
Shaquille O’Neal joins Turner Sports as analyst
By BRIAN MAHONEY, AP Basketball Writer
Jul 14, 2:58 pm EDT
The calls came as soon as Shaquille O’Neal(notes) decided to retire, all wanting to hire one of the NBA’s greatest entertainers.
TNT’s “Inside the NBA” studio show had been O’Neal’s favorite as a player, so the choice was easy.
Get ready for the Big Analyzer, Big Commentator, or whatever other nickname he takes in the next phase of his career.
O’Neal agreed Thursday to a multiyear deal with Turner Sports to become an analyst on its NBA coverage, where he will fold his 7-foot-1 frame into the fourth chair on the TNT set alongside Charles Barkley, Kenny Smith and Ernie Johnson.
“I’m just going to try to make it more fun than it already is,” O’Neal said during a conference call.
O’Neal also will contribute to NBA TV and NBA.com, and his agreement includes a development deal with Turner’s entertainment and animation networks.
O’Neal said he had offers from ABC/ESPN and others upon retiring last month, but quickly chose the Turner offer, saying he wasn’t interested in creating a bidding war for his services.
A four-time NBA champion during his 19-year career, O’Neal also had one of the NBA’s biggest personalities, with Turner Sports president David Levy calling him one of the most “dominant, popular and charismatic players in the NBA.” So O’Neal, who says he still one day expects to run for sheriff, was expected to quickly find work in the entertainment industry upon his retirement if he wanted it.
“The addition of `The Big Analytical’ will be terrific,” Smith said in a statement. “I can’t wait to make verbal passes to the most dominant center of our time.”
O’Neal will be part of TNT’s coverage of All-Star weekend—scheduled next season for Orlando, his first NBA home—and the playoffs. He doesn’t think it will be difficult having to criticize Kobe Bryant(notes), whom he feuded with as Lakers teammates, or any other players.
“I have the ability and the backing to give fair criticism. The only time I have trouble with people giving criticism is when they haven’t walked that walk,” O’Neal said. “I’ve walked many walks in my 19-year career, so I think any criticism that I give should be fair.”
He showed a strong opinion in his first day on the job when referring to the state of the center position with himself and Yao Ming(notes) deciding to retire within a month of each other.
“The beasts are now gone, the Goliaths are now gone, so that leaves Dwight Howard(notes) out there by himself,” O’Neal said of Orlando’s All-Star center. “So if he doesn’t win two or three championships, I’ll be very disappointed, because he has no competition out there now. None. Zero.”
A 15-time All-Star, O’Neal decided to retire in fifth place on the league’s career scoring list after he was slowed by injuries in recent seasons. Even as his game suffered, he remained one of the NBA’s most popular players and should fit right in on the fourth seat of the TNT studio show, occupied mostly last season by Chris Webber.
Neither O’Neal nor Levy had any concern about O’Neal finding room to give his insight with Barkley and Smith already in place.
“Shaq knows the game and, on and off the floor, he has always been entertaining; a guy who gets it,” Johnson said.
O’Neal said he also expects to work on cartoons and TV shows, adding he’s interested in being the executive producer for a program.
--------------------------------------------------------------------------------
LAKERS ARE READY FOR THIS LOCK OUT TO END AND GO FOR THE TITLE AGAIN!!!!!!!!
Not what I wanted to see today.. Its Ok we are getting Higer High's and Higher Lows....
Lookin to close out the week on a strong Note..
Almost winks!!
Strong Close.. Be Strong and Safe Friday Winks.. Email me if you need me buddy
Hold Tight. Lets Make this Close on the HOD...
Yes a sell last week would have been great and rare I get out on top!
I hear You.. One of the Few Plays I will be holding more then 40days ...
Very Solid play
Testing that Dollar Again......
Going to be a RED ONE HERE FOR TSPT
Add more volume and will be going for the $1 again
READY FOR TAKE OFF!! RUN WAY IS CLEAR FOR TAKE OFF!!!!!!
Good day of trading to open up the week here for DVAX
Green Light!!
Good Morning Winks and everybody.. Looking to Break down the $1 wall and use it as support this week...
Must be something in the pipeline...
Good Morning Everybody....
Super Strong Week Here boyz. Have a Great weekend.. More to be made on Monday!!
Super Strong Week Here for DRL...
Proxy Soliciting Materials (revised) (PRER14A)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant þ
Filed by a Party other than the Registrant o
Check the appropriate box:
þ Preliminary Proxy Statement - Amendments to Form of Proxy Card
o Confidential, for Use of the Commission Only (as permitted by Rule 14a- 6(e)(2) )
o Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material Pursuant to §240.14a-12
Doral Financial Corporation
(Name of Registrant as Specified in its Charter)
Payment of Filing Fee (Check the appropriate box):
þ No fee required.
o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
Gotta Buy now or already own it cause the Chase Game is Starting from Now till Nov......
HIGHER HIGH's AND HIGHER LOW's!!
WE TALKING ABOUT THAT DOLLAR!!!!!!!!!!!!!!!!
Cyclacel Pharmaceuticals, Inc. Announces Closing of Underwritten Offering of Common Stock and Warrants
Cyclacel Pharmaceuticals, Inc. (MM) (NASDAQ:CYCC)
Intraday Stock Chart
Today : Friday 8 July 2011
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), today announced that it has closed its previously announced underwritten offering of an aggregate of 7,617,646 units at an offering price of $1.36 per unit for gross proceeds of $10.36 million. Each unit consists of (i) one share of common stock and (ii) a five-year warrant to purchase 0.5 of a share of common stock at an exercise price of $1.36 per share, exercisable beginning six months after the date of issuance. The shares of common stock and warrants are immediately separable and were issued separately such that no units were issued.
The net proceeds, after underwriting discounts and commissions and other estimated fees and expenses payable by the Company, and assuming the warrants are not exercised, are approximately $9.3 million. The net proceeds from the offering will be used for funding the Company's SEAMLESS pivotal Phase 3 trial of its leading drug, sapacitabine, and general corporate purposes.
Leerink Swann LLC and Lazard Capital Markets LLC served as Joint Book-running Managers for the offering. Roth Capital Partners, LLC served as financial advisor.
The securities described above were sold by Cyclacel pursuant to a shelf registration statement previously filed with and declared effective by the Securities and Exchange Commission (SEC) on April 26, 2011. A prospectus supplement related to the offering dated June 30, 2011 is available on the SEC's web site at http://www.sec.gov. The prospectus supplement and accompanying prospectus may be obtained by sending a request to Leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, telephone number: 617-918-4814.
About Cyclacel Pharmaceuticals, Inc.
Cyclacel is a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Sapacitabine (CYC682), a cell cycle modulating nucleoside analog, is in Phase 3 development for the treatment of acute myeloid leukemia in the elderly and Phase 2 studies for myelodysplastic syndromes and lung cancer. Seliciclib (CYC202 or R-roscovitine), a CDK (cyclin dependent kinase) inhibitor, is in Phase 2 studies for the treatment of lung cancer and nasopharyngeal cancer and in a Phase 1 trial in combination with sapacitabine. Cyclacel's ALIGN Pharmaceuticals subsidiary markets directly in the U.S. Xclair® Cream for radiation dermatitis, Numoisyn® Liquid and Numoisyn® Lozenges for xerostomia. Cyclacel's strategy is to build a diversified biopharmaceutical business focused in hematology and oncology based on a portfolio of commercial products and a development pipeline of novel drug candidates. Please visit www.cyclacel.com for additional information.
Forward-looking Statements
This news release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, the efficacy, safety, and intended utilization of Cyclacel's product candidates, the conduct and results of future clinical trials, plans regarding regulatory filings, future research and clinical trials and plans regarding partnering activities. Factors that may cause actual results to differ materially include the risk that product candidates that appeared promising in early research and clinical trials do not demonstrate safety and/or efficacy in larger-scale or later clinical trials, trials may have difficulty enrolling, Cyclacel may not obtain approval to market its products, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborative partners for further clinical trials, development and commercialization of product candidates. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plans," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties the Company faces, please refer to our most recent Annual Report on Form 10-K and other periodic and current filings that have been filed with the Securities and Exchange Commission and are available at www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
© Copyright 2011 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. Numoisyn®
GOOD MORNING!!!!! Looking for that $1 today here....
No Doubt@! 5 bagger here before Nov..
DRL & IGXT ARE VERY STRONG PLAYERS RIGHT NOW..
ENJOY!
Give me that dollar!!!!!!!!!!
dough ray me/$$$ I love when you use that winks!
$1 IS HERE SOON!
DRL IS ON FIRE!!!!!! $2.50 JUST PRINTED!!
HERE WE COME $3
3 weeks later its trading $2.30 up over .60cents.... Volume nice also...
GOOD MORNING EVERYBODY!!!!!!!!!!
TRADING VERY STRONG!!
I think the Bottom is near for CYCC before it legs up again...
What I tell ya Yesterday NYRA? Those .82's are $$ in the Bank today!
WINKS BUDDY!! You gotta just bulk buy down low instead of chasing these stocks...
Im not selling Yet but I got some shares if u need some buddy!
Why stop at 3 winks... 5 Bagger waiting to happen here...
Ohh Ohhhh Those .65's are making me smile now......